Status: current, Defined. Date: 31-Mar 2011. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3976321000168111 | Risedronate (Apo) 35 mg tablet, 8, blister pack | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 3976331000168114 | Risedronate (Apo) (risedronate sodium 35 mg) tablet, 8 tablets, blister pack (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Risedronate (Apo) 35 mg tablet, 8, blister pack | has TPUU | Risedronate (Apo) 35 mg tablet | true | Inferred relationship | Some | 1 | |
| Risedronate (Apo) 35 mg tablet, 8, blister pack | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Risedronate (Apo) 35 mg tablet, 8, blister pack | Is a | Risedronate (Apo) 35 mg tablet, 8 | true | Inferred relationship | Some | ||
| Risedronate (Apo) 35 mg tablet, 8, blister pack | has container type | blister pack | true | Inferred relationship | Some | ||
| Risedronate (Apo) 35 mg tablet, 8, blister pack | has TP | Risedronate (Apo) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Containered trade product pack reference set
FHIR